These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 20233133)
1. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case-control study. Liang XL; Liu SX; Chen YH; Yan LJ; Li H; Xuan HJ; Liang YZ; Shi W Biomarkers; 2010 Jun; 15(4):332-9. PubMed ID: 20233133 [TBL] [Abstract][Full Text] [Related]
2. Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury. Ren H; Zhou X; Dai D; Liu X; Wang L; Zhou Y; Luo X; Cai Q BMC Nephrol; 2015 Aug; 16():142. PubMed ID: 26283194 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Liangos O; Tighiouart H; Perianayagam MC; Kolyada A; Han WK; Wald R; Bonventre JV; Jaber BL Biomarkers; 2009 Sep; 14(6):423-31. PubMed ID: 19572801 [TBL] [Abstract][Full Text] [Related]
4. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Parikh CR; Mishra J; Thiessen-Philbrook H; Dursun B; Ma Q; Kelly C; Dent C; Devarajan P; Edelstein CL Kidney Int; 2006 Jul; 70(1):199-203. PubMed ID: 16710348 [TBL] [Abstract][Full Text] [Related]
5. Urinary KIM-1, IL-18 and Cys-c as early predictive biomarkers in gadolinium-based contrast-induced nephropathy in the elderly patients. Duan SB; Liu GL; Yu ZQ; Pan P Clin Nephrol; 2013 Nov; 80(5):349-54. PubMed ID: 24040783 [TBL] [Abstract][Full Text] [Related]
6. Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage? Tekce BK; Uyeturk U; Tekce H; Uyeturk U; Aktas G; Akkaya A Ann Clin Biochem; 2015 Jan; 52(Pt 1):88-94. PubMed ID: 24670880 [TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. Ho J; Lucy M; Krokhin O; Hayglass K; Pascoe E; Darroch G; Rush D; Nickerson P; Rigatto C; Reslerova M Am J Kidney Dis; 2009 Apr; 53(4):584-95. PubMed ID: 19070948 [TBL] [Abstract][Full Text] [Related]
8. Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Tu Y; Wang H; Sun R; Ni Y; Ma L; Xv F; Hu X; Jiang L; Wu A; Chen X; Chen M; Liu J; Han F Ren Fail; 2014 Nov; 36(10):1559-63. PubMed ID: 25154466 [TBL] [Abstract][Full Text] [Related]
9. Angiopoietin/Tie2 Dysbalance Is Associated with Acute Kidney Injury after Cardiac Surgery Assisted by Cardiopulmonary Bypass. Jongman RM; van Klarenbosch J; Molema G; Zijlstra JG; de Vries AJ; van Meurs M PLoS One; 2015; 10(8):e0136205. PubMed ID: 26309217 [TBL] [Abstract][Full Text] [Related]
10. Urinary biomarkers of acute kidney injury in deceased organ donors--kidney injury molecule-1 as an adjunct to predicting outcome. Field M; Dronavalli V; Mistry P; Drayson M; Ready A; Cobbold M; Inston N Clin Transplant; 2014 Jul; 28(7):808-15. PubMed ID: 24801162 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Prabhu A; Sujatha DI; Ninan B; Vijayalakshmi MA Ann Vasc Surg; 2010 May; 24(4):525-31. PubMed ID: 20363104 [TBL] [Abstract][Full Text] [Related]
12. Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. Gil HW; Yang JO; Lee EY; Hong SY Clin Toxicol (Phila); 2009 Nov; 47(9):870-5. PubMed ID: 19827907 [TBL] [Abstract][Full Text] [Related]
13. Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study. Carvalho Pedrosa D; Macedo de Oliveira Neves F; Cavalcante Meneses G; Pinheiro Gomes Wirtzbiki G; da Costa Moraes CA; Costa Martins AM; Braga Libório A Pediatr Nephrol; 2015 Dec; 30(12):2207-13. PubMed ID: 26248472 [TBL] [Abstract][Full Text] [Related]
14. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Bonventre JV Scand J Clin Lab Invest Suppl; 2008; 241():78-83. PubMed ID: 18569971 [TBL] [Abstract][Full Text] [Related]
15. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687 [TBL] [Abstract][Full Text] [Related]
16. The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review. Huang Y; Don-Wauchope AC Inflamm Allergy Drug Targets; 2011 Aug; 10(4):260-71. PubMed ID: 21539514 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery. Arthur JM; Hill EG; Alge JL; Lewis EC; Neely BA; Janech MG; Tumlin JA; Chawla LS; Shaw AD; Kidney Int; 2014 Feb; 85(2):431-8. PubMed ID: 24005224 [TBL] [Abstract][Full Text] [Related]
18. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Portilla D; Dent C; Sugaya T; Nagothu KK; Kundi I; Moore P; Noiri E; Devarajan P Kidney Int; 2008 Feb; 73(4):465-72. PubMed ID: 18094680 [TBL] [Abstract][Full Text] [Related]
19. Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice. Medić B; Rovčanin B; Basta Jovanović G; Radojević-Škodrić S; Prostran M Biomed Res Int; 2015; 2015():854070. PubMed ID: 26697493 [TBL] [Abstract][Full Text] [Related]
20. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. Tuladhar SM; Püntmann VO; Soni M; Punjabi PP; Bogle RG J Cardiovasc Pharmacol; 2009 Mar; 53(3):261-6. PubMed ID: 19247188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]